help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on February 6, 2007
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-2599
A more recent version of this article appeared on May 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
92/5/1666    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Darzy, K. H.
Right arrow Articles by Shalet, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Darzy, K. H.
Right arrow Articles by Shalet, S. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-ARGININE
Medline Plus Health Information
*Pituitary Disorders
*Radiation Therapy

Submitted on November 27, 2006
Accepted on January 30, 2007

Cranial irradiation and growth hormone neurosecretory dysfunction: a critical appraisal

Ken H. Darzy, Suzan S. Pezzoli, Michael O. Thorner, and Stephen M. Shalet*

Department of Endocrinology, Christie Hospital (K.H.D. and S.M.S.), Manchester, United Kingdom, M20 4BX; and the Department of Medicine, University of Virginia Health Science Center (M.O.T. and S.S.P.), Charlottesville, Virginia 22908, USA

* To whom correspondence should be addressed. E-mail: stephen.m.shalet{at}man.ac.uk.

Context: It has been suggested that radiation-induced growth hormone neurosecretory dysfunction exists in children; however, the pathophysiology is poorly understood and it is unknown if such a phenomenon exists in adult life. Study subjects: 24-hour spontaneous GH secretion was studied by 20 min sampling both in the fed state (n=16; 6 women) and the last 24 hours of 33-hour fast (n=10; 3 women) in adult cancer survivors of normal GH status defined by two GH provocative tests, 13.1 ± 1.6 (range 3-28) yr after cranial irradiation (18-40Gy) for non-pituitary brain tumors (n=12) or leukemia (n=4) in comparison with 30 (9 women) age-, and BMI-matched normal controls (fasting, 11 men and 3 women). Results: Using previously published diagnostic thresholds, all patients had stimulated peak GH responses in the normal range to both, the insulin tolerance test and the combined GHRH plus arginine stimulation test, as well as normal individual mean profile GH levels during the fed and fasting states. However, gender specific comparisons revealed marked reduction (by 40%) in the overall peak GH responses to both provocative tests but similar GH secretory profiles; no differences were seen in the pulsatile attributes of GH secretion (cluster analysis) or the profile absolute and mean GH levels in the fed state or when the h-p axis was stimulated by fasting. Conclusions: Radiation-induced GHNSD either does not exist or is a very rare phenomenon in irradiated adult cancer survivors. The normality of physiological GH secretion in the context of reduced maximum somatotroph reserve suggests compensatory overdrive of the partially damaged somatotroph axis and constitutes a relative argument against somatotroph dysfunction being explained purely by hypothalamic damage with secondary atrophy due to GHRH deficiency. It is therefore possible that radiation in doses less than 40Gy causes dual damage to both the pituitary and the hypothalamus.


Key words: Brain tumors • Cranial irradiation • Radiotherapy • Growth hormone deficiency • GHD • GH secretion • Hypopituitarism • Pituitary • Hypothalamus • h-p axis • GH neurosecretory dysfunction • GH neuroregulation • GHNSD • ITT • GHRH • Arginine • Late effects







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society